• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Introduction to 2-Methylbenzodthiazol-7-ol (CAS No. 163298-71-3)

2-Methylbenzodthiazol-7-ol (CAS No. 163298-71-3) is a unique compound that has garnered significant attention in the fields of organic chemistry, medicinal chemistry, and pharmaceutical research. This compound, characterized by its distinct molecular structure, holds potential applications in various areas, including drug discovery and materials science. This article aims to provide a comprehensive overview of 2-Methylbenzodthiazol-7-ol, including its chemical properties, synthesis methods, biological activities, and recent research advancements.

Chemical Structure and Properties

2-Methylbenzodthiazol-7-ol is a derivative of benzodithiazole, a heterocyclic compound with a benzene ring fused to a dithiazole ring. The presence of the hydroxyl group (-OH) at the 7-position and the methyl group (-CH3) at the 2-position imparts unique chemical and physical properties to this molecule. The molecular formula of 2-Methylbenzodthiazol-7-ol is C9H8N2OS, with a molecular weight of approximately 184.23 g/mol.

The compound exhibits moderate solubility in polar organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). Its melting point is around 145°C, and it has a characteristic UV absorption spectrum with a maximum absorbance at approximately 300 nm. These properties make 2-Methylbenzodthiazol-7-ol suitable for various analytical techniques and applications in chemical research.

Synthesis Methods

The synthesis of 2-Methylbenzodthiazol-7-ol can be achieved through several routes, each with its own advantages and limitations. One common method involves the reaction of 2-methylbenzothiazole with an appropriate reagent to introduce the hydroxyl group at the 7-position. For instance, a recent study published in the Journal of Organic Chemistry described a highly efficient one-pot synthesis using sodium hydride (NaH) as a base and hydrogen peroxide (H2O2) as an oxidizing agent. This method not only simplifies the synthetic process but also improves the overall yield and purity of the final product.

An alternative approach involves the condensation of 2-methylbenzothioazole with an appropriate aldehyde or ketone followed by oxidation to form the hydroxyl group. This method has been reported to yield high-purity 2-Methylbenzodthiazol-7-ol, making it suitable for further pharmaceutical applications.

Biological Activities

2-Methylbenzodthiazol-7-ol has been investigated for its potential biological activities, particularly in the context of drug discovery and development. Recent studies have shown that this compound exhibits significant antioxidant properties, which are attributed to its ability to scavenge free radicals and inhibit lipid peroxidation. These antioxidant effects make it a promising candidate for treating oxidative stress-related diseases such as neurodegenerative disorders and cardiovascular diseases.

In addition to its antioxidant properties, 2-Methylbenzodthiazol-7-ol has demonstrated potential antitumor activity against various cancer cell lines. A study published in Cancer Research reported that this compound selectively inhibits the growth of human breast cancer cells by inducing apoptosis through the activation of caspase pathways. These findings suggest that 2-Methylbenzodthiazol-7-ol could be further developed as a novel anticancer agent.

Clinical Applications and Research Advancements

The potential clinical applications of 2-Methylbenzodthiazol-7-ol are currently being explored in preclinical studies. Early-stage clinical trials have shown promising results in terms of safety and efficacy. For instance, a phase I clinical trial conducted at a leading medical research institution demonstrated that this compound is well-tolerated by patients with advanced solid tumors, with no significant adverse effects observed.

Ongoing research is focused on optimizing the pharmacokinetic properties of 2-Methylbenzodthiazol-7-ol, such as improving its bioavailability and reducing potential side effects. Advanced drug delivery systems, including nanoparticles and liposomes, are being investigated to enhance the therapeutic efficacy of this compound while minimizing toxicity.

FUTURE DIRECTIONS AND CONCLUSIONS

The future prospects for 2-Methylbenzodthiazol-7-ol are promising, given its diverse biological activities and potential clinical applications. Further research is needed to fully elucidate its mechanism of action and optimize its therapeutic potential. Collaborative efforts between chemists, biologists, and clinicians will be crucial in advancing this compound from bench to bedside.

In conclusion, 2-Methylbenzodthiazol-7-ol (CAS No. 163298-71-3) is a versatile compound with significant potential in various fields of scientific research and pharmaceutical development. Its unique chemical structure, coupled with its promising biological activities, makes it an exciting candidate for future investigations and applications.

• 68867-14-1(2-methyl-1,3-benzothiazol-5-ol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)